WATERBURY, Conn. (AP) – A judge won’t toss a class action lawsuit alleging employees at a Connecticut hospital used the same insulin injection pens on multiple diabetic patients, putting them at risk of HIV or other blood-borne diseases.
The Connecticut Post reports (http://bit.ly/2kV5qPr ) the Superior Court judge ruled that a jury will decide whether Griffin Hospital is liable for the staff’s alleged negligence. A trial date hasn’t been set.Related Content: Misused insulin pens at Griffin Hospital could mean risk of deadly disease for patients
In 2014, hospital CEO Patrick Charmel had sent a letter to 3,149 former patients saying it had “identified the possibility” that insulin pens ordered for patients hospitalized between September 2008 and May 7, 2014 “may have been misused.”Related Content: Thousands potentially affected by possible insulin pen misuse
The suit claims that as many as 11 employees at the Derby hospital used the same insulin pens on patients.
A hospital spokeswoman declined to comment.
___
Information from: Connecticut Post, http://www.connpost.com
Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
